We are live on
!
Find out more
SC
Slow Capital Portfolio holdings
AUM
$857M
Turnover
6.31%
1-Year Est. Return
38.3%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
+38.3%
3 Year Est. Return
+123.69%
5 Year Est. Return
+154.77%
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$9.05M
(-3.6%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
22.66%
Holding
176
New
16
Increased
46
Reduced
97
Closed
10
Avg Time Held
1.1
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSCJ
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
|
+$2.48M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$911K |
| 3 |
Invesco Preferred ETF
PGX
|
+$883K |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$720K |
| 5 |
Fidelity MSCI Real Estate Index ETF
FREL
|
+$492K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kezar Life Sciences
KZR
|
+$3.65M |
| 2 |
Blackstone
BX
|
+$2.15M |
| 3 |
iShares MBS ETF
MBB
|
+$1.68M |
| 4 |
ExxonMobil
XOM
|
+$1.35M |
| 5 |
Weyerhaeuser
WY
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.52% |
| 2 | Technology | 19.12% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Healthcare | 10.05% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
AT&T
T
$161B
| $325K | 0.13% |
+12,840
| New | +$308K |
2019 Q2
0 quarters
|
|
152
iShares Global Comm Services ETF
IXP
$612M
| $324K | 0.13% |
5,664
-257
| -4% | -$14.8K |
2019 Q1
1 quarter
|
|
153
WisdomTree US Multifactor Fund
USMF
$267M
| $322K | 0.13% |
10,697
+108
| +1% | +$3.19K |
2019 Q1
1 quarter
|
|
154
iShares S&P 500 Value ETF
IVE
$49.9B
| $309K | 0.13% |
+2,654
| New | +$304K |
2019 Q2
0 quarters
|
|
155
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$379M
| $281K | 0.12% |
5,046
-1,108
| -18% | -$60.3K |
2019 Q1
1 quarter
|
|
156
McDonald's
MCD
$172B
| $277K | 0.11% |
1,333
-61
| -4% | -$12.1K |
2019 Q1
1 quarter
|
|
157
Biogen
BIIB
$34.8B
| $269K | 0.11% |
1,152
+271
| +31% | +$62.6K |
2017 Q4
6 quarters
|
|
|
EPZM
158
DELISTED
Epizyme, Inc
EPZM
| $269K | 0.11% |
21,423
-4,136
| -16% | -$53.2K |
2019 Q1
1 quarter
|
|
159
Innovator US Equity Ultra Buffer ETF April
UAPR
$160M
| $267K | 0.11% |
+10,424
| New | +$264K |
2019 Q2
0 quarters
|
|
160
Procter & Gamble
PG
$365B
| $254K | 0.1% |
2,317
+86
| +4% | +$9.17K |
2019 Q1
1 quarter
|
|
161
SolarEdge
SEDG
$1.93B
| $234K | 0.1% |
3,749
-4,694
| -56% | -$237K |
2018 Q1
5 quarters
|
|
162
Vanguard Real Estate ETF
VNQ
$36.7B
| $232K | 0.1% |
+2,659
| New | +$233K |
2019 Q2
0 quarters
|
|
|
BSJL
163
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
| $226K | 0.09% |
+9,153
| New | +$226K |
2019 Q2
0 quarters
|
|
|
164
iShares MBS ETF
MBB
$35.9B
| $222K | 0.09% |
2,065
-15,802
| -88% | -$1.68M |
2019 Q1
1 quarter
|
|
165
PepsiCo
PEP
$175B
| $206K | 0.09% |
+1,568
| New | +$201K |
2019 Q2
0 quarters
|
|
166
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $195K | 0.08% |
+15,000
| New | +$192K |
2019 Q2
0 quarters
|
|
|
167
Blackstone
BX
$87.1B
| – | – |
-61,599
| Closed | -$2.15M | – |
|
168
Chevron
CVX
$430B
| – | – |
-10,291
| Closed | -$1.27M | – |
|
169
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.2B
| – | – |
-8,267
| Closed | -$356K | – |
|
170
iShares Global Energy ETF
IXC
$3.21B
| – | – |
-8,222
| Closed | -$277K | – |
|
|
171
DELISTED
Kezar Life Sciences
KZR
| – | – |
-20,554
| Closed | -$3.65M | – |
|
172
Regeneron Pharmaceuticals
REGN
$82B
| – | – |
-2,213
| Closed | -$909K | – |
|
173
VF Corp
VFC
$6.68B
| – | – |
-4,534
| Closed | -$371K | – |
|
|
174
Weyerhaeuser
WY
$14B
| – | – |
-48,982
| Closed | -$1.29M | – |
|
|
175
ExxonMobil
XOM
$718B
| – | – |
-16,654
| Closed | -$1.35M | – |
|
Similar funds
MCM
AAM
AIMC
QIM
SFO
UW
PWG
EWA
Slow Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Slow Capital held 176 positions worth $242M, down 3.6% from $251M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Slow Capital withdrew a net $17.7M in Q2 2019, closing 10 positions and reducing 97 holdings. Its most notable exit was Kezar Life Sciences, an estimated $3.65M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Slow Capital opened a new position in Invesco BulletShares 2019 Corporate Bond ETF worth $2.63M.
- Slow Capital's largest Q2 2019 buy was Invesco BulletShares 2019 Corporate Bond ETF: 117,559 shares worth $2.63M.
- Slow Capital added most to iShares S&P 500 Growth ETF in Q2 2019, an estimated $323K increase.
- Slow Capital's biggest Q2 2019 reduction was iShares MBS ETF, cutting an estimated $1.68M.
- Slow Capital fully exited Kezar Life Sciences in Q2 2019, selling an estimated $3.65M.
- Slow Capital's ten largest holdings make up 23% of its $242M portfolio in Q2 2019.
- Slow Capital opened 16 new positions and closed 10 in Q2 2019.
- Slow Capital's portfolio value fell 3.6% quarter-over-quarter to $242M.
Based on Slow Capital's 13F filing for Q2 2019, filed 1 Aug 2019.